Photodynamic therapy with topical 5-aminolevulinic acid as a post-operative adjuvant therapy for an incompletely resected primary nasopharyngeal papillary adenocarcinoma: A case report

Lasers in Surgery and Medicine

Volumn 38, Issue 5, 2006, Pages 435-438

  Wang, Cheng Ping ^a   Chang, Yih Leong ^a   Chen, Chin Tin ^b   Yang, Ting Hua ^a   Lou, Pei Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Chemoradiation; Nasopharyngeal cancer; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; CARBOMER; CARBOPOL 971P; PHOTOSENSITIZING AGENT; POLOXAMER;

ABSENCE OF SIDE EFFECTS; ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG FORMULATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; NASOPHARYNX CARCINOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; TREATMENT OUTCOME; WOUND HEALING;

ADENOCARCINOMA, PAPILLARY; ADMINISTRATION, TOPICAL; ADULT; AMINOLEVULINIC ACID; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NASOPHARYNGEAL NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 33745727957     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20291     Document Type: Article

References (23)

1. Vanhasselt CA, Ng HK. Papillary adenocarcinoma of the nasopharynx. J Laryngol Otol 1991;105:853-854.
2. Kuo TT, Tsang NM. Salivary gland type nasopharyngeal carcinoma-A histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma. Am J Surg Pathol 2001;25:80-86.
3. Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma-A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol 1988;12:946-953.
4. Samaan NA, Schultz PN, Ordonez NG, Hickey RC, Johnston DA. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 1987;64:219-223.
5. Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004;91:441-446.
6. Lou PJ, Jones L, Hopper C. Clinical outcomes of photodynamic therapy for head-and-neck cancer. Technol Cancer Res Treat 2003;2:311-317.
7. Biel MA. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 1998;108:1259-1268.
8. D'Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients. Head Neck 2004;26:232-240.
9. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-387.
10. Betz CS, Lai JP, Xiang W, Janda P, Heinrich P, Stepp H, Baumgartner R, Leunig A. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci 2002;1:315-319.
11. Tong MC, vanHasselt CA, Woo JKS. Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 1996;253:189-192.
12. Schmolka IR. Artificial skin. 1. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571-582.
13. Cinberg JZ, Solomon MP, Ozbardacki G. Thyroid-carcinoma and secondary malignancy of the sinonasal tract. Arch Otolaryngol Head Neck Surg 1980;106:239-241.
14. Monchik JM, De Petris G, De Crea C. Occult papillary carcinoma of the thyroid presenting as a cervical cyst. Surgery 2001;129:429-432,
15. Verge J, Guixa J, Alejo M, Basas C, Quer X, De Castro J, Autonell J, Serra C. Cervical cystic lymph node metastasis as first manifestation of occult papillary thyroid carcinoma: Report of seven cases. Head Neck 1999;21:370-374.
16. Nishikawa M, Toyoda N, Yonemoto T, Fujiyama A, Ogawa Y, Tokoro T, Sakaguchi N, Yoshimura M, Yoshikawa N, Tabata S, Kumazawa H, Yamashita T, Sakaida N, Okamura A, Kasagi K, Inada M. Occult papillary thyroid carcinoma in Hashimoto's thyroiditis presenting as a metastatic bone tumor. Endocr J 1998;45:111-116.
17. Lin JD, Chao TC, Weng HF, Huang HS, Ho YS. Clinical presentations and treatment for 74 occult thyroid carcinoma-Comparison with nonoccult thyroid carcinoma in Taiwan. Am J Clin Oncol 1996;19:504-508.
18. Chen ST, Shieh HY, Lin JD, Chang KSS, Lin KH. Overexpression of thyroid hormone receptor beta 1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line. J Endocrinol 2000;165:379-389.
19. Wei WI, Ho CM, Yuen PW, Fung CF, Sham JST, Lam KH. Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch Otolaryngol Head Neck Surg 1995;121:638-642.
20. Fan KFM, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78:1374-1383.
21. Chen HM, Chen CT, Yang H, Kuo MY, Kuo YS, Lan WH, Wang YP, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol 2004;40:630-637.
22. Chen HM, Chen CT, Yang H, Lee MI, Kuo MY, Kuo YS, Wang YP, Tsai T, Chiang CP. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med 2005;34:253-256.
23. Tsai JC, Chiang CP, Chen HM, Huang SB, Wang CW, Lee MI, Hsu YC, Chen CT, Tsai T. Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med 2004;34:18-24.